Works matching AU La Motta, Concettina


Results: 44
    1
    2
    3
    4
    5
    6
    7
    8

    Aldose reductase inhibitors: 2013-present.

    Published in:
    Expert Opinion on Therapeutic Patents, 2019, v. 29, n. 3, p. 199, doi. 10.1080/13543776.2019.1582646
    By:
    • Quattrini, Luca;
    • La Motta, Concettina
    Publication type:
    Article
    9

    Recent advances in the use of tyrosine kinase inhibitors against thyroid cancer.

    Published in:
    Expert Opinion on Pharmacotherapy, 2024, v. 25, n. 12, p. 1667, doi. 10.1080/14656566.2024.2393281
    By:
    • Ferrari, Silvia Martina;
    • Patrizio, Armando;
    • Stoppini, Giulio;
    • Elia, Giusy;
    • Ragusa, Francesca;
    • Balestri, Eugenia;
    • Botrini, Chiara;
    • Rugani, Licia;
    • Barozzi, Emilio;
    • Mazzi, Valeria;
    • La Motta, Concettina;
    • Antonelli, Alessandro;
    • Fallahi, Poupak
    Publication type:
    Article
    10
    11

    Soyasaponins from Zolfino bean as aldose reductase differential inhibitors.

    Published in:
    Journal of Enzyme Inhibition & Medicinal Chemistry, 2019, v. 34, n. 1, p. 350, doi. 10.1080/14756366.2018.1553166
    By:
    • Balestri, Francesco;
    • De Leo, Marinella;
    • Sorce, Carlo;
    • Cappiello, Mario;
    • Quattrini, Luca;
    • Moschini, Roberta;
    • Pineschi, Carlotta;
    • Braca, Alessandra;
    • La Motta, Concettina;
    • Da Settimo, Federico;
    • Del-Corso, Antonella;
    • Mura, Umberto
    Publication type:
    Article
    12

    Lenvatinib: an investigational agent for the treatment of differentiated thyroid cancer.

    Published in:
    Expert Opinion on Investigational Drugs, 2021, v. 30, n. 9, p. 913, doi. 10.1080/13543784.2021.1972971
    By:
    • Ferrari, Silvia Martina;
    • Elia, Giusy;
    • Ragusa, Francesca;
    • Paparo, Sabrina Rosaria;
    • Mazzi, Valeria;
    • Miccoli, Mario;
    • Galdiero, Maria Rosaria;
    • Varricchi, Gilda;
    • Foddis, Rudy;
    • Guglielmi, Giovanni;
    • Spinelli, Claudio;
    • La Motta, Concettina;
    • Benvenga, Salvatore;
    • Antonelli, Alessandro;
    • Fallahi, Poupak
    Publication type:
    Article
    13
    14

    Antineoplastic Effect of ALK Inhibitor Crizotinib in Primary Human Anaplastic Thyroid Cancer Cells with STRN–ALK Fusion In Vitro.

    Published in:
    International Journal of Molecular Sciences, 2024, v. 25, n. 12, p. 6734, doi. 10.3390/ijms25126734
    By:
    • Ferrari, Silvia Martina;
    • Ragusa, Francesca;
    • Elia, Giusy;
    • Mazzi, Valeria;
    • Balestri, Eugenia;
    • Botrini, Chiara;
    • Rugani, Licia;
    • Patrizio, Armando;
    • Piaggi, Simona;
    • La Motta, Concettina;
    • Ulisse, Salvatore;
    • Virili, Camilla;
    • Antonelli, Alessandro;
    • Fallahi, Poupak
    Publication type:
    Article
    15
    16

    Antineoplastic Activity of Pazopanib in Anaplastic Thyroid Cancer in Primary Culture.

    Published in:
    International Journal of Molecular Sciences, 2023, v. 24, n. 3, p. 2398, doi. 10.3390/ijms24032398
    By:
    • Ferrari, Silvia Martina;
    • Elia, Giusy;
    • Ragusa, Francesca;
    • Paparo, Sabrina Rosaria;
    • Mazzi, Valeria;
    • Patrizio, Armando;
    • Piaggi, Simona;
    • Baldini, Enke;
    • Centanni, Marco;
    • La Motta, Concettina;
    • Antonelli, Alessandro;
    • Fallahi, Poupak
    Publication type:
    Article
    17

    Preclinical Development of FA5, a Novel AMP-Activated Protein Kinase (AMPK) Activator as an Innovative Drug for the Management of Bowel Inflammation.

    Published in:
    International Journal of Molecular Sciences, 2021, v. 22, n. 12, p. 6325, doi. 10.3390/ijms22126325
    By:
    • Antonioli, Luca;
    • Pellegrini, Carolina;
    • Fornai, Matteo;
    • Benvenuti, Laura;
    • D'Antongiovanni, Vanessa;
    • Colucci, Rocchina;
    • Bertani, Lorenzo;
    • Di Salvo, Clelia;
    • Semeghini, Giorgia;
    • La Motta, Concettina;
    • Giusti, Laura;
    • Zallocco, Lorenzo;
    • Ronci, Maurizio;
    • Quattrini, Luca;
    • Angelucci, Francesco;
    • Coviello, Vito;
    • Oh, Won-Keun;
    • Ha, Quy Thi Kim;
    • Németh, Zoltan H.;
    • Haskó, Gyorgy
    Publication type:
    Article
    18
    19
    20

    CLM3, a Multitarget Tyrosine Kinase Inhibitor With Antiangiogenic Properties, Is Active Against Primary Anaplastic Thyroid Cancer In Vitro and In Vivo.

    Published in:
    2014
    By:
    • Antonelli, Alessandro;
    • Bocci, Guido;
    • Fallahi, Poupak;
    • La Motta, Concettina;
    • Ferrari, Silvia Martina;
    • Mancusi, Caterina;
    • Fioravanti, Anna;
    • Di Desidero, Teresa;
    • Sartini, Stefania;
    • Corti, Alessandro;
    • Piaggi, Simona;
    • Materazzi, Gabriele;
    • Spinelli, Claudio;
    • Fontanini, Gabriella;
    • Danesi, Romano;
    • Da Settimo, Federico;
    • Miccoli, Paolo
    Publication type:
    Journal Article
    21

    Novel Pyrazolopyrimidine Derivatives as Tyrosine Kinase Inhibitors with Antitumoral Activity in Vitro and in Vivo in Papillary Dedifferentiated Thyroid Cancer.

    Published in:
    Journal of Clinical Endocrinology & Metabolism, 2011, v. 96, n. 2, p. E288, doi. 10.1210/jc.2010-1905
    By:
    • Antonelli, Alessandro;
    • Bocci, Guido;
    • La Motta, Concettina;
    • Ferrari, Silvia Martina;
    • Fallahi, Poupak;
    • Fioravanti, Anna;
    • Sartini, Stefania;
    • Minuto, Michele;
    • Piaggi, Simona;
    • Corti, Alessandro;
    • Alì, Greta;
    • Berti, Piero;
    • Fontanini, Gabriella;
    • Danesi, Romano;
    • Da Settimo, Federico;
    • Miccoli, Paolo
    Publication type:
    Article
    22
    23
    24

    Derivatives of Benzimidazol-2-ylquinoline and Benzimidazol-2-ylisoquinoline as Selective A<sub>1</sub> Adenosine Receptor Antagonists with Stimulant Activity on Human Colon Motility.

    Published in:
    ChemMedChem, 2011, v. 6, n. 10, p. 1909, doi. 10.1002/cmdc.201100284
    By:
    • Cosimelli, Barbara;
    • Taliani, Sabrina;
    • Greco, Giovanni;
    • Novellino, Ettore;
    • Sala, Annalisa;
    • Severi, Elda;
    • Da Settimo, Federico;
    • La Motta, Concettina;
    • Pugliesi, Isabella;
    • Antonioli, Luca;
    • Fornai, Matteo;
    • Colucci, Rocchina;
    • Blandizzi, Corrado;
    • Daniele, Simona;
    • Trincavelli, Maria Letizia;
    • Martini, Claudia
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34

    A New Vista of Aldehyde Dehydrogenase 1A3 (ALDH1A3): New Specific Inhibitors and Activity-Based Probes Targeting ALDH1A3 Dependent Pathways in Glioblastoma, Mesothelioma and Other Cancers.

    Published in:
    Cancers, 2024, v. 16, n. 13, p. 2397, doi. 10.3390/cancers16132397
    By:
    • Magrassi, Lorenzo;
    • Pinton, Giulia;
    • Luzzi, Sabino;
    • Comincini, Sergio;
    • Scravaglieri, Andrea;
    • Gigliotti, Valentina;
    • Bernardoni, Bianca Laura;
    • D'Agostino, Ilaria;
    • Juretich, Francesca;
    • La Motta, Concettina;
    • Garavaglia, Silvia
    Publication type:
    Article
    35

    A<sub>1</sub> adenosine receptor antagonists, 3-aryl[1,2,4]triazino[4,3- a]benzimidazol-4-(10 H)-ones (ATBIs) and N-alkyl and N-acyl-(7-substituted-2-phenylimidazo[1,2- a][1,3,5]triazin-4-yl)amines (ITAs): Different recognition of bovine and human binding sites

    Published in:
    Drug Development Research, 2004, v. 63, n. 1, p. 1, doi. 10.1002/ddr.10366
    By:
    • Da Settimo, Federico;
    • Primofiore, Giampaolo;
    • Taliani, Sabrina;
    • La Motta, Concettina;
    • Novellino, Ettore;
    • Greco, Giovanni;
    • Lavecchia, Antonio;
    • Cosimelli, Barbara;
    • Iadanza, Manuela;
    • Klotz, Karl-Norbert;
    • Tuscano, Daniela;
    • Trincavelli, Maria Letizia;
    • Martini, Claudia
    Publication type:
    Article
    36
    37
    38

    Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo.

    Published in:
    Oncology Reports, 2018, v. 39, n. 5, p. 2306, doi. 10.3892/or.2018.6305
    By:
    • Ferrari, Silvia Martina;
    • Bocci, Guido;
    • Di Desidero, Teresa;
    • Ruffilli, Ilaria;
    • Elia, Giusy;
    • Ragusa, Francesca;
    • Fioravanti, Anna;
    • Orlandi, Paola;
    • Paparo, Sabrina Rosaria;
    • Patrizio, Armando;
    • Piaggi, Simona;
    • Motta, Concettina La;
    • Ulisse, Salvatore;
    • Baldini, Enke;
    • Materazzi, Gabriele;
    • Miccoli, Paolo;
    • Antonelli, Alessandro;
    • Fallahi, Poupak
    Publication type:
    Article
    39

    Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo.

    Published in:
    Oncology Reports, 2018, v. 39, n. 5, p. 2225, doi. 10.3892/or.2018.6306
    By:
    • Ferrari, Silvia Martina;
    • Bocci, Guido;
    • Di Desidero, Teresa;
    • Elia, Giusy;
    • Ruffilli, Ilaria;
    • Ragusa, Francesca;
    • Orlandi, Paola;
    • Paparo, Sabrina Rosaria;
    • Patrizio, Armando;
    • Piaggi, Simona;
    • Motta, Concettina La;
    • Ulisse, Salvatore;
    • Baldini, Enke;
    • Materazzi, Gabriele;
    • Miccoli, Paolo;
    • Antonelli, Alessandro;
    • Fallahi, Poupak
    Publication type:
    Article
    40
    41
    42
    43
    44